The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

Zygomatic implants represent one of the most significant advances in treatment options for seniors with severe maxillary bone loss.

Innovaccer Inc., a leading healthcare AI company, today announced that Beckman Coulter Diagnostics, a global clinical diagnostics leader and a Danaher company, has selected Gravity, Innovaccer’s ...

Chicago, Jan. 27, 2026 (GLOBE NEWSWIRE) -- The global clinical data management system market was valued at 4.08 billion in 2024 and is expected to reach US$ 10.35 billion by 2033, growing at a CAGR of ...

The partnership connects structured clinical data with EHR workflows to accelerate referrals, care coordination, and ...

“Our partnership with CRIO accelerates our strategy connecting site-level eSource and the Medidata Platform,” said Tom Doyle, chief technology officer, Medidata. “This will accelerate workflows for ...

As a CMS-approved QCDR, OneOncology is authorized to collect clinical data from a variety of sources and report MIPS measures for partner practices and their clinicians across all of their EMR ...

A recent influx of digital technology has unlocked tremendous potential for clinical trials. For an industry that has traditionally relied on patients’ paper intake forms and manual data entry into ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

The recent acquisition of Flatiron by Roche raises two important questions: First, given that (as Andrew Matzkin of Health Advances observed) the Flatiron transaction is “putting smiles on a lot of ...